INTRODUCTION
the procedure costly, and life-long immune suppression is required. Strategies to reduce hepatic fibrosis and avoid the The liver responds to persistent inflammation from multiple causes, including viral infection, alcohol ex-need for organ transplantation have focused on hepatic stellate cells (HSC), the principal collagen-producing cess, and hepatic steatosis, with a wound-healing, fibrogenic response that in some patients can lead to cirrho-cell in the liver. Many antifibrotic therapies have been explored but none have become available yet for clinical sis, portal hypertension, hepatocellular carcinoma, and liver failure. These serious disorders are associated with use (35) . Recent reports have shown that transplantation of embryonic stem cells (ESC) and adult hematopoietic significant mortality risk and impose considerable financial burdens on health care systems worldwide. Liver and mesenchymal stem cells (MSC) into animals with experimental liver injury can result in transdifferentia-transplantation is the only curative therapy for end-stage disease, but access to sufficient donors is problematic, tion of these cells into hepatocytes and in reduced fibro-sis (4, 10, 11, 21, 29, 32) , although not all authors have woman. The study was approved by the Southern Health Human Research Ethics Committee. demonstrated positive results (8) . Adverse outcomes, such as tumor formation by ESC-derived hepatocytes (4) Animals and fusion of MSC with host cells to form dysplastic precursors, have been observed (37). In addition, there Six-week-old male C57/BL6 mice were purchased from Monash Animal Services, Melbourne, Australia. is considerable evidence that bone marrow is a source of profibrogenic cells in the liver and that bone marrow-
The study was approved by the Animal Ethics Committee, Monash University. Animals received humane care derived MSC transdifferentiate into cells capable of supporting hepatic fibrogenesis (13) .
under the Australian code of practice for the care and use of animals for scientific purposes. Alternatively, there are stem-like cells that may overcome the disadvantages of ESC and MSC. We and oth-Cell Isolation ers have shown that human amnion epithelial cells (hAEC) display features of pluripotent/multipotent stem hAEC were isolated from amnion membranes and their purity assessed as described previously (14) . cells and can transdifferentiate into several lineages derived from each of the primary germ layers, including Briefly, the tissue was digested twice in 0.25% trypsin/ EDTA solution (Gibco, Grand Island, NY) for 20 min hepatocytes (14, 20) . The cells are plentiful; in excess of 100 million hAEC can be obtained noninvasively from with agitation at 37°C. Trypsin was inactivated with fetal calf serum (Invitrogen, Carlsbad, CA) and dispersed the amnion membrane of term delivered placenta, a hugely abundant and noncontentious source of stem cells washed in DMEM-F12 medium (Gibco). Batches >99% positive for the epithelial markers cytokeratin-7, cells for potential cellular therapies. Interestingly, primary undifferentiated hAEC produce a number of hepa-8/18 (Dako, Glostrup, Denmark) by flow cytometry (14) were used in the experiments described below. tocyte specific proteins, including serum albumin (24, 30) , and can engraft in the murine liver as demon-Induction of Hepatic Fibrosis and Cell Transplantation strated in a study exploring the use of hAEC as a transgene carrier for the treatment of inherited liver diseases Mice were given intraperitoneal injections with CCl 4 (1 µl/g body weight diluted 1:10 in olive oil) twice (27).
Importantly, unlike ESC, hAEC do not form terato-weekly for 4 weeks. CCl 4 administration induces necroinflammatory liver injury that reproducibly causes mas or tumors following xenotransplantation (14, 20) . These cells have also been successfully transplanted into hepatic fibrosis. Midway through the CCl 4 treatment, animals received hAEC (2 × 10 6 in 250 µl saline) via the allogeneic recipients because they appear to lack key allo-recognition molecules that would elicit host im-tail vein. Previous dose-response experiments using 1-4 × 10 6 cells showed that 2 × 10 6 was the optimal cell mune responses (15) . Further, anti-inflammatory properties have been attributed to hAEC and amnion mem-dose for infusion (data not shown). Control groups consisted of mice given CCl 4 only, CCl 4 + saline (vehicle brane and employed clinically as topical therapy in ophthalmic and dermal applications to promote wound control), and healthy mice that did not undergo any treatment. Each cohort consisted of 8-10 mice. Animals healing and reduce scarring (31) . A recent study investigating the effects of a mixed cell population consisting were culled 4 weeks after commencing the experiment and blood and liver tissue collected. Spleen, heart, and of hAEC and amnion-derived MSC reported a reduction in fibrosis in lungs of bleomycin-injured mice (6) . How-lungs were also collected from mice given hAEC. ever, whether the anti-inflammatory properties of hAEC Detection of Human Cells by DNA PCR can be exploited following cell transplantation to reduce fibrosis remains largely unknown. In the present study,
To determine if hAEC were present in murine organs, DNA was extracted from liver, lung, spleen, and heart we transplanted hAEC into immune competent C57/BL6 mice with carbon tetrachloride (CCl 4 )-induced hepatic tissue using phenol chloroform and amplified by PCR using primers specific for human Alu repeat sequences fibrosis and show that hAEC xenografts survive, continue to secrete albumin, and reduce hepatic inflamma- (9) . DNA extracted from healthy mouse liver served as a control. tion and fibrosis.
MATERIALS AND METHODS

Detection of Human Serum Albumin Human Amnion Tissue
Albumin secreted by primary, undifferentiated hAEC has been measured in sera of SCID mice harboring am-Amnion membranes were obtained from healthy women with a normal singleton pregnancy undergoing nion tissue transplants (27). As an indirect measure of hAEC survival and functionality, sera collected from cesarean section at term (37-40 weeks gestation; n = 16). Informed written consent was obtained from each C57/BL6 mice (hAEC treated and controls; n = 10/ group) were tested for human serum albumin using an overnight at 4°C with 1:100 diluted caspase-3 antibody (Promega, Madison, WI). After several washes sections ELISA specific for the human protein (Bethyl Laboratories, Montgomery, TX), following the manufacturer's were incubated sequentially with biotinylated goat antimouse secondary antibodies, ABC kit reagents (Vector instructions.
Laboratories Burlinghame, CA); antibody binding was Measurement of Alanine Aminotransferase (ALT) detected with DAB. and Total Bilirubin
To localize α-smooth muscle actin (α-SMA), present in activated HSC, liver tissue sections were placed in Serum ALT and bilirubin were measured by Southern Cross Pathology, Monash Medical Centre using reagents an autostainer (Dako) and incubated sequentially with: peroxidase block (Dako), CAS protein block (Zymed, and calibrators from Beckmann-Coulter (Sydney, Australia).
San Francisco, CA), 1:5000 diluted α-SMA antibody (Sigma-Aldrich), 1:300 diluted rabbit anti-mouse IgG2a Hepatic Cytokine Concentrations (Invitrogen), ABC reagents (Vector Laboratories), and DAB (Dako). Incubations were carried out at room tem-Liver tissue was homogenized in 50 mM Tris-HCl, 150 mM NaCl, 1% Triton X-100, 0.5% Tween-20, 0.1% perature for 15 min except primary antibody (30 min) and DAB (5 min). Slides were counterstained with he-SDS, 1 mM EDTA, and protease inhibitor cocktail (Roche), sonicated, and centrifuged at 14,000 × g for 15 matoxylin, dehydrated, and mounted in DPX. min to remove debris. Interleukin (IL)-6, IL-10, tumor
Picro Sirius Red Staining necrosis factor-α (TNF-α), and monocyte chemoattractant protein (MCP)-1 were measured by the Cytometric Deparaffinized liver tissue sections were stained with Picro Sirius Red to identify the extent of histological fi-Bead Array (BD Biosciences, San Jose, CA) and IL-1 and transforming growth factor-β (TGF-β) by ELISA brosis. Sections were incubated for 90 min in Picro Sirius Red stain, washed in acetic acid and water (5:1000), de-(R&D Systems, Minneapolis, MN). Total protein content in tissue lysates was determined by the BCA assay hydrated in ethanol, and mounted in DPX. Fibrosis area was measured by computer-assisted morphometry. Fifteen (Thermo Scientific, Rockford, IL) and cytokine concentrations normalized against the total protein content.
consecutive nonoverlapping fields were acquired from each mouse liver; the images were digitized and fibrosis Immunohistochemistry area analyzed by Scion Image for Windows (vAlpha 4.0.3.2, Scion Corporation, Frederick, MD). hAEC present in the liver were identified using human inner mitochondrial membrane (IMM) protein and Hydroxyproline Assay human leukocyte antigen (HLA)-G. For IMM, 4% paraformaldehyde-fixed paraffin-embedded liver tissue sec-Hepatic collagen content was measured by the hydroxyproline assay, as described previously (25) , with tions 5 µm in thickness were dewaxed, rehydrated, and antigen retrieval carried out by boiling the sections in minor modifications. Briefly, liver tissue was hydrolyzed in 6N HCl and absorbance measured at 558 nm. citrate buffer. Endogenous peroxidase activity was quenched in 0.6% H 2 O 2 for 15 min. HLA-G immunohis-
The hydroxyproline content was calculated from a standard curve prepared with trans-4-hydroxy-L-proline tochemistry was performed on OCT-embedded frozen liver tissue sections, 4 µm in thickness, fixed in 2% (Sigma-Aldrich), data were multiplied by a factor of 6.94 to convert the hydroxyproline measurement to collagen paraformaldehyde for 10 min. Protein block (Dako, Glostrup, Denmark) was applied for 15 min followed by content and expressed per milligram of wet tissue weight. IMM (1:100, Chemicon, Boronia, Australia) or HLA-G Gelatin Zymography antibodies (1:50, BD Biosciences) and incubated at 37°C for 1 h. Human term fetal membranes served as a Matrix metalloproteinases (MMPs) were extracted from mouse liver tissue (n = 4/group). MMP-2 and positive control. Isotype-matched mouse IgG was applied to sections serving as negative controls. Sections MMP-9 activity was assessed by gelatin zymography as described previously (36) . Densitometry of the active were then incubated with biotinylated goat anti-mouse secondary antibodies followed by Envision kit reagents MMP bands was performed using a GS- contribute to the reduction in inflammatory indices such We and others have shown that hAEC express plurias serum ALT, an outcome demonstrated in other forms potent and some mesenchymal stem cell markers includof experimental liver injury (18) . Caspase-3-positive ing Oct-4, Sox-2, Nanog, SSEA-4, Tra-1-60, Tra-1-80, cells were significantly more frequent in CCl 4 -treated GCTM2, CD29, CD73, and CD166, have low levels of mice compared to healthy animals (p < 0.001) ( Fig. 3A . HLA class IA antigens, high levels of the class IB anti-Mice given CCl 4 + hAEC showed significantly fewer gen HLA-G, and lack HLA class II molecules. hAEC apoptotic hepatocytes (p < 0.05). Staining of serial secare negative for the hematopoietic lineage markers tions showed the presence of IMM-positive hAEC in CD31, CD34, and monocytic marker CD45 (14,20, these regions (Fig. 3B ). We also investigated whether 24,26). These cells were injected intravenously into im-hAEC transplantation induced hepatocyte proliferation. mune competent C57/BL6 mice 2 weeks after exposure While PCNA-positive cells were present throughout heto CCl 4 and culled 2 weeks later. Intact IMM and HLApatic lobules and portal tracts, significant differences G-positive cells were detected in liver sections from 8
were absent among treatment groups (data not shown). of 10 mice tested and were observed around portal tracts hAEC Decrease Hepatic Inflammation and spreading into surrounding hepatic lobules ( Fig.  1A ). Due to limitations in IMM antibody binding to par-Given the reduction in hepatocyte apoptosis, we then affin sections and HLA-G to frozen sections, colocalizaasked whether there might also be hAEC-associated tion using serial sections could not be carried out. hAEC changes in pro-and anti-inflammatory cytokines. Liver lining amnion of term fetal membranes were positive tissue lysates from healthy mice and animals given CCl 4 for IMM and HLA-G. Liver tissue sections from mice with or without hAEC were analyzed using a flow cyreceiving CCl 4 only and those incubated with mouse IgG tometry-based assay or ELISA. Mice transplanted with lacked IMM and HLA-G staining.
hAEC had significantly reduced IL-6 and TNF-α and DNA PCR for human Alu repeat sequences was carincreased IL-10 hepatic protein content compared with ried out to detect human cells in liver of CCl 4 -treated mice given CCl 4 alone (p < 0.01, p < 0.0001, and p < mice. Human DNA was detected in mouse liver of 4 of 0.01, respectively) ( Fig. 4) . IL-1 and MCP-1 protein lev-5 hAEC-treated animals. In order to determine if hAEC els did not alter with hAEC treatment. had engrafted in other organs, spleen, heart, and lung hAEC Reduce HSC Activation tissues were also examined. Human DNA was detected Activated HSC and Kupffer cells release inflammain spleen and lungs of 3 of 5 mice and heart tissue of tory cytokines including TNF-α and IL-6. Because 1of 5 mice tested.
hAEC transplantation led to a reduction in TNF-α and As an indirect measure of the presence and function-IL-6, we investigated whether HSC activation was simiality of hAEC, we also tested for human albumin 2 larly reduced. As expected, the number of α-SMA-posiweeks post-cell transplantation. Human albumin was detive cells was significantly elevated in CCl 4 -treated mice tected in murine sera from all CCl 4 + hAEC-treated anicompared with healthy controls (p < 0.001) ( Fig. 5 ). mals and was absent in sera of mice treated with CCl 4 CCl 4 -treated mice given hAEC demonstrated signifior saline vehicle, confirming the specificity of the cantly fewer α-SMA-positive cells compared with CCl 4 ELISA (Fig. 1B) . alone (p < 0.001). Using serial sections, IMM-positive hAEC Transplantation Reduces Serum ALT hAEC were found in close proximity to residual α-Elevations in bilirubin and ALT generally reflect he-SMA-stained cells (Fig. 5B) . patocyte injury and these proteins increased significantly hAEC Reduce Hepatic Fibrosis Area in animals given CCl 4 compared to healthy controls and TGF-β Content (p < 0.05 and p < 0.001, respectively) ( Fig. 2) . Serum ALT was significantly lower in mice injected with Because HSC are the principal collagen-producing cells in the liver, we next examined whether reduced hAEC compared to CCl 4 alone (p < 0.01). Although serum bilirubin was lower in mice receiving hAEC com-HSC activation was associated with reduced hepatic fibrosis demonstrated by Sirius red staining and quantita-pared to CCl 4 alone, this reduction was not statistically significant.
tion by computer-assisted morphometry. After 4 weeks of CCl 4 treatment, fibrotic bands were clearly evident by cantly lower hepatic collagen content compared with CCl 4 alone (p < 0.05).
Sirius red staining and fibrosis area was significantly increased in CCl 4 -treated animals compared to untreated
To explore mechanisms that could lead to a reduction in HSC activation, we measured the profibrotic cytokine controls (p < 0.001) ( Fig. 6A ). However, mice given hAEC showed significantly less fibrosis area compared TGF-β in hepatic tissue lysates by ELISA normalized by protein content. TGF-β content increased significantly in with CCl 4 alone (p < 0.001). IMM-positive cells were found adjacent to some of the fibrotic bands that were response to CCl 4 compared to normal controls (p < 0.001) but was significantly lower in mice treated with still evident in hAEC-treated mice (Fig. 6B) .
We also assessed whether the histological changes CCl 4 + hAEC (p < 0.01) (Fig. 7B ). We also measured changes in enzymes that alter extracellular matrix com-seen in fibrosis area were reflected in the hepatic collagen content. Hepatic collagen concentration, measured position by degrading collagen. Active MMP-2 increased twofold in mice treated with hAEC compared to by the hydroxyproline assay, was significantly elevated in CCl 4 -treated mice compared to healthy controls (p < mice given CCl 4 alone (p < 0.05) (Fig. 7C) . Active MMP-9, however, was not significantly altered with 0.001) (Fig. 7) . hAEC-treated animals showed signifi- hAEC treatment, compared to that measured in the CCl 4 tokeratin-19 immunohistochemistry to identify the human cells (6) . Although factors regulating the migration group alone (Fig. 7C) . and engraftment of the transplanted hAEC remain un-DISCUSSION known, chemokines, adhesion molecules, and liverspecific factors such as sphingosine 1-phosphate may In this study we have shown that hAEC engraft in livers of immunocompetent mice and reduce CCl 4 -play a role (19) . We did not observe any histological evidence of host induced hepatic fibrosis. hAEC engraftment was demonstrated by the presence of intact human IMM and HLA-rejection of transplanted hAEC, which were present in portal tracts and adjacent parenchyma without the neutro-G-positive cells 2 weeks posttransplantation while the presence of human albumin, a protein known to be se-phil or lymphocyte infiltration typical of immune-mediated rejection. Similar observations have been made fol-creted by the transplanted cells (24, 30) , in mouse serum suggests that the hAEC remain viable. Analysis for hu-lowing transplantation of hAEC into bonnet monkeys with spinal cord injury (28) . This may be due to factors man DNA in several murine organs showed that the intravenously transplanted hAEC traffic primarily to the such as low levels of expression of HLA class IA and II molecules and costimulatory molecules (3,14) or active injured liver. Consistent with these findings, Bailo et al. reported the presence of human DNA in swine and ro-inhibition of host T-cell proliferation (2,34). hAEC are known to express HLA-G, which serves not only as a dent organs several weeks after the transplantation of hAEC together with human amnion MSC (2). These marker to follow the fate of the transplanted cells but is also likely to play an important role in subverting the cells were also found in lungs of bleomycin-injured C57/ BL6 mice, 2 weeks post-cell transplantation through cy-host immune response to these cells. HLA-G is a non- classical, nonpolymorphic class I molecule that was first were implicated in fibrosis reduction. However, while engraftment of a large number of Wharton's jelly MSC described in choriocarcinoma cells (7) and is expressed in fetal-placental cells that invade the maternal uterus and fibrosis reduction was demonstrated with this technique, the authors noted that direct hepatic injection may and thus may modulate the maternal immune response against the fetus (17) . In addition to inhibiting prolifera-be complicated by postprocedural bleeding that could potentially impair fibrosis reduction by inducing plate-tion of alloreactive T cells (1), HLA-G may also constrain host immune responses by stimulating IL-10 pro-let-derived growth factor leading to HSC activation. The antifibrotic properties of hAEC have not been duction by regulatory T cells (22). In this context it is interesting to note that we found increased IL-10 protein previously investigated in experimental liver fibrosis. In chronic liver injury, activation of HSC by TGF-β, the levels in hepatic tissue lysates from hAEC-treated mice.
Multipotent stem cells can also be harvested from hu-prototypical fibrogenic cytokine, leads to production of collagen and other extracellular matrix components. We man umbilical cord. Recently, human umbilical cord MSC (hUMSC) have been shown to decrease CCl 4 -found that hAEC infusion in CCl 4 -treated immunocompetent mice was associated with a significant decrease induced hepatic fibrosis in rodent models. Jung et al. (16) derived hUMSC from cord blood samples and in hepatic TGF-β content with fewer α-SMA-positive cells, suggesting decreased HSC activation. In addition, showed a decrease in markers of hepatic fibrogenesis that was most prominent 4 weeks following tail vein CCl 4 -treated mice showed less histological fibrosis and lower hepatic collagen content following hAEC infusion infusion. Tsai et al. (33) injected hUMSC obtained from Wharton's jelly directly into the liver and showed de-compared to controls given CCl 4 alone. The development of this fibrolytic phenotype may occur through re-creased hepatic collagen and TGF-β content in treated rats almost to control levels. Reduced hepatic inflamma-duction of proinflammatory signals that activate HSC and through the increased activity of collagen degrading tion and release of bioactive factors and cytokines in association with Wharton's jelly cell transplantation enzymes following hAEC transplantation.
CCl 4 -treated mice infused with hAEC showed lower nificantly fewer apoptotic hepatocytes than animals given CCl 4 alone. Thus, inhibition of hepatocyte apopto-hepatic tissue levels of the proinflammatory cytokines IL-6 and TNF-α with increased expression of the anti-sis, which is a potent stimulus for hepatic fibrogenesis, may be an additional mechanism leading to hAEC-inflammatory cytokine IL-10. This antifibrotic cytokine profile may reflect a direct interaction between hAEC induced fibrosis reduction. Increased expression of collagen-degrading enzymes and HSC in which hAEC-derived factors regulate HSC activation. In support of this hypothesis, a recent study such as matrix metalloproteinases is thought to be an important mechanism underlying fibrosis regression showed that IL-6 expression by cultured HSC induced MSC secretion of IL-10 leading to decreased HSC colla-(12). Our finding that hAEC infusion was associated with a twofold increase in MMP-2 activity compared to gen production (23) . Alternatively, hAEC may alter profibrogenic activation signals for Kupffer cells and HSC that seen in mice treated with CCl 4 alone supports the development of a hAEC-associated fibrolytic state and by reducing hepatocyte apoptosis. In the process of removing damaged cells, engulfment of apoptotic hepato-is consistent with increased MMP-2 activity identified by others during fibrosis regression in CCl 4 -treated rats cytes by Kupffer cells and HSC leads to their activation with increased TGF-β expression, TNF-α secretion, and (39) . The cellular source of MMP-2 during fibrosis regression is unclear because HSC secrete MMP-2 yet death-receptor expression (5) and can lead to liver fibrosis (38) . Prevention of hepatocyte apoptosis by inhibit-HSC apoptosis is an important mechanism of fibrosis resolution (39) , and we identified a significant decrease ing death-receptor-mediated pathways can prevent experimental liver fibrosis (40) . In this context, we found in activated HSC following hAEC transfusion. In our study, MMP-2 expression was significantly greater in that CCl 4 -treated mice infused with hAEC showed sig- ident liver cells remains unclear.
In conclusion, we found that hAEC transplantation REFERENCES effectively reduces experimental hepatic fibrosis by re- 
